Abstract
In this issue of Blood, Man et al investigate the therapeutic potential of Polo-like kinase 4 (PLK4) in TP53 mutated and wild-type acute myeloid leuke......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
